1 Photos and videos
Lev Bubis retweeted
9 Apr 2022
A short history (14 slides) of adjuvant therapy for pancreatic cancer #TheAmylaseSchool #HiloAEG #UEGambassador #GItwitter @EurPancClub @YouppiePancreas @maloehr1 @lelecapurso #PancreaticCancer
👇👇👇
3
47
78
Lev Bubis retweeted
20 Jan 2022
#GI22
📢Before the meeting gets rolling, I would like to present the abstracts I am keeping my eye👁️on
My Top 10(ish) #PancreaticCancer abstracts
and
My Top 10 non-pancreatic abstracts
6
24
79
Lev Bubis retweeted
30 Jun 2021
PATCH-DP: a single-arm phase II trial of intra-operative application of HEMOPATCH™ to the pancreatic stump to preve… pubmed.ncbi.nlm.nih.gov/3417…
1
6
7
Lev Bubis retweeted
23 Aug 2019
New @ICESOntario study led by @LevBubis & @alyson_mahar looked at patient-reported symptom severity among 22,650 cancer outpatients in the last 6 months of life sciencedirect.com/science/ar…
2
2
Lev Bubis retweeted
22 Aug 2019
Congratulations @niv_vela on his GOLDEN STETHOSCOPE AWARD!! An Outstanding @uoftmedicine #medstudent in the Peters-Boyd Academy @Sunnybrook!!
Great work presented @SocSurgOnc on costs/benefits of adjuvant therapy for #pancreascancer-should be published soon!
1
1
28
Lev Bubis retweeted
9 Aug 2019
Our study in @AATSJournals looking at esophagectomy readmissions in Ontario:
1. No change in readmission rate over 13 yrs
2. Same at thoracic & non-thoracic centres
3. 18% readmitted at 'best' centre
Not all readmissions are 'bad'
doi.org/10.1016/j.jtcvs.2019…
#tssmn #SoMe4Surgery
29 Mar 2019
Rescue is a 🔑 part of high-volume / centre of excellence care. On a related point, readmission is a form of outpatient rescue. We need 🏨 leaders to recognise that many surgical readmissions are necessary, not indicators of ⬇️ quality! #tssmn @biniamkidaneMD @DrNCoburn
1
9
22
Lev Bubis retweeted
9 Jul 2019
Important info on pt-reported symptom burden after #NET diagnosis now in @OncJournal. Frequent symptoms and burden persists over 5y.
Now, need to use this data to ⬆️ early & longitudinal supportive care 🦓 @CNETSCanada
Supported by @NANETS1 @IRSC_CIHR
onlinelibrary.wiley.com/doi/…
1
5
11
Lev Bubis retweeted
24 Jun 2019
Incorporating Patient Preferences in Non-inferiority Trials: Our proposal to improve the clinical utility and interpretation of non-inferiority trials @JAMA_current @enenbee @tyler_chesney @UofTSurgery
jamanetwork.com/journals/jam…
1
5
18
Lev Bubis retweeted
29 Jul 2018
An assessment of 23,840 Stage I-III breast cancer patients shows high rates of symptom burden, especially in younger women, more advanced stage, lower income patients. Can we use this data to improve symptoms during treatment? authors.elsevier.com/a/1XNhN…
5
9
Lev Bubis retweeted
21 Jul 2018
Cancer-related fatigue (CRF) is increasingly recognised as one of the most common and distressing side effects of cancer and its treatments.
It has a negative impact on work, social... powerfulpatients.org/2017/08…
1
19
26
Lev Bubis retweeted
22 Jun 2018
Individualized post-op management w/ e-health using patient reported outcomes, a RCT @TheLancet thelancet.com/journals/lance…
thelancet.com/journals/lance…
14
35
Lev Bubis retweeted
7 Jun 2018
Can we improve surgical outcomes by promoting exercise, nutrition, and lifestyle modifications prior to major operations? @Sunnybrook team has created a #prehab program for cancer patients @CancerCare_ON
ncbi.nlm.nih.gov/pubmed/2986…
13
31
Phase III trial: People with surgically removed pancreatic cancer who received mFOLFIRINOX chemo lived a median of 20 months longer than those who received gemcitabine bit.ly/2JcgHnh #ASCO18
4
89
135
Lev Bubis retweeted
5 Jun 2018
PRODIGE 7 : HIPEC added to cytoreductive surgery for isolated CRC peritoneal mets does not improve OS and increases late post-op complications
9
9
Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) nej.md/2JkWbEu #ASCO18
3
216
274
Lev Bubis retweeted
11 May 2018
Immunoscore for the classification of #coloncancer: study provides a reliable estimate of the risk of recurrence in patients with colon cancer @sitcancer hubs.ly/H0c2fLc0
2
24
23
Lev Bubis retweeted
5 May 2018
Congratulations to Yunni Jeong for her Best Presentation Award at the 2018 Korean Gastric Cancer Association meeting! @UofTSurgery @mygutfeelingca
1
4
17
Congratulations to @DrNCoburn! So very well-deserved! x.com/ShadyAshamalla/status/…
1
Laura Davis from @DrNCoburn's team presenting research on province-wide cancer patient-reported outcomes data at CCO Research Day 2018! @ICESOntario @Sunnybrook #PROs #CancerResearch
5